Inventor · disambiguated record
Lioudmila Tchistiakova
Also filed as: TCHISTIAKOVA LIOUDMILA · TCHISTIAKOVA LIOUDMILA G · TCHISTIAKOVA LIOUDMILA GENNADIEVNA
39 granted patents·21 pending applications·726 citations·filing 2001–2023
98Inventor score
Top patents by PatentIndex Score
60 records- 0197US7888486B2Antagonist antibodies against GDF-8WYETH LLC·Filed 2006·Granted Feb 15, 2011·86 cites·22 claims
- 0297US7501121B2IL-13 binding agentsWYETH CORP·Filed 2005·Granted Mar 10, 2009·112 cites·41 claims
- 0396US7615213B2Antibodies against human interleukin-13 and pharmaceutical compositions thereofWYETH CORP·Filed 2005·Granted Nov 10, 2009·100 cites·85 claims
- 0495US8586049B2Antibody-drug conjugatesGERBER HANS-PETER·Filed 2012·Granted Nov 19, 2013·41 cites·11 claims
- 0595US8309094B2Antibody-drug conjugatesGERBER HANS-PETER·Filed 2012·Granted Nov 13, 2012·59 cites·6 claims
- 0695US8044178B2Anti-5T4 antibodies and uses thereofWYETH LLC·Filed 2007·Granted Oct 25, 2011·41 cites·31 claims
- 0794US8415459B2Antibody to GDF8 and uses thereofLAVALLIE EDWARD ROLAND·Filed 2008·Granted Apr 9, 2013·54 cites·20 claims
- 0893US8956608B2Method for treating sarcopenia using antagonist antibodies against GDF-8WYETH LLC·Filed 2013·Granted Feb 17, 2015·16 cites·19 claims
- 0992US8372625B2Polynucleotides encoding antagonist antibodies against GDF-8WYETH LLC·Filed 2011·Granted Feb 12, 2013·16 cites·23 claims
- 1092US7910107B2Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disordersWYETH LLC·Filed 2009·Granted Mar 22, 2011·29 cites·14 claims
- 1191US10392438B2Bispecific antibodiesPFIZER·Filed 2015·Granted Aug 27, 2019·9 cites·24 claims
- 1291US9475870B2Single domain binding moleculeTHE UNIV COURT OF THE UNIV OF ABERDEEN·Filed 2016·Granted Oct 25, 2016·9 cites·20 claims
- 1391US8759495B2Anti-5T4 antibodies and uses thereofBOGHAERT ERWIN R·Filed 2011·Granted Jun 24, 2014·22 cites·33 claims
- 1491US8496934B2Method for treating cachexia using antagonist antibodies against GDF-8WYETH LLC·Filed 2012·Granted Jul 30, 2013·13 cites·19 claims
- 1590US6733755B2Ligand for vascular endothelial growth factor receptorSUPRATEK PHARMA INC·Filed 2001·Granted May 11, 2004·46 cites·16 claims
- 1687US8349327B2Method for treating muscular dystrophy using antagonist antibodies against GDF-8WYETH LLC·Filed 2011·Granted Jan 8, 2013·7 cites·16 claims
- 1787US8221752B2Antibodies against human interleukin-13 and uses thereforKASAIAN MARION T·Filed 2009·Granted Jul 17, 2012·18 cites·2 claims
- 1886US9644025B2Immunotherapy regimes dependent on ApoE statusBLACK RONALD·Filed 2008·Granted May 9, 2017·15 cites·27 claims
- 1983US9926368B2Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8WYETH LLC·Filed 2015·Granted Mar 27, 2018·3 cites·19 claims
- 2083US9902771B2Anti-5T4 antibodies and uses thereofWYETH LLC·Filed 2015·Granted Feb 27, 2018·3 cites·20 claims
- 2182US10647756B2Humanized antibodiesPFIZER·Filed 2016·Granted May 12, 2020·2 cites·14 claims
- 2282US10287341B2Single domain binding moleculeTHE UNIV COURT OF THE UNIV OF ABERDEEN·Filed 2016·Granted May 14, 2019·2 cites·15 claims
- 2382US9884921B2Bispecific heterodimeric diabodies and uses thereofPFIZER·Filed 2015·Granted Feb 6, 2018·4 cites·34 claims
- 2482US9433687B2Anti-Notch3 antibodies and antibody-drug conjugatesPFIZER·Filed 2013·Granted Sep 6, 2016·6 cites·64 claims
- 2576US7943342B2Nucleic acids encoding IL-13 binding agentsWYETH LLC·Filed 2009·Granted May 17, 2011·2 cites·58 claims
- 2675US11147852B2Engineered antibody constant regions for site-specific conjugation and methods and uses thereforPFIZER·Filed 2012·Granted Oct 19, 2021·1 cites·27 claims
- 2775US9850301B2Antibody to GDF8 and uses thereofWYETH LLC·Filed 2016·Granted Dec 26, 2017·1 cites·20 claims
- 2873US11434292B2Antibodies specific for CD3 and uses thereofPFIZER·Filed 2019·Granted Sep 6, 2022·1 cites·20 claims
- 2973US9828428B2Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugatesPFIZER·Filed 2013·Granted Nov 28, 2017·2 cites·23 claims
- 3073US6696274B2Ligand for enhancing oral and CNS delivery of biological agentsSUPRATEK PHARMA INC·Filed 2001·Granted Feb 24, 2004·3 cites·17 claims
- 3172US11692025B2Single domain binding moleculeELASMOGEN LTD·Filed 2021·Granted Jul 4, 2023·0 cites·34 claims
- 3271US9272030B2Use of tau to monitor immunotherapyBLACK RONALD·Filed 2011·Granted Mar 1, 2016·1 cites·16 claims
- 3365US2010173382A1Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugatesWYETH CORP·Filed 2009·Application pending·0 cites
- 3464US11034756B2Single domain binding moleculeELASMOGEN LTD·Filed 2019·Granted Jun 15, 2021·0 cites·17 claims
- 3564US2010021483A1Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugatesWYETH CORP·Filed 2009·Application pending·0 cites
- 3663US10189896B2Antibody to GDF8 and uses thereofWYETH LLC·Filed 2017·Granted Jan 29, 2019·0 cites·24 claims
- 3762US2014308302A1Anti-5t4 antibodies and uses thereofWYETH LLC·Filed 2014·Application pending·0 cites
- 3861US9127060B2Anti-Notch1 antibodiesGELES KENNETH G·Filed 2011·Granted Sep 8, 2015·1 cites·9 claims
- 3961US7112654B2Ligand for vascular endothelial growth factor receptorSUPRATEK PHARMA INC·Filed 2004·Granted Sep 26, 2006·1 cites·6 claims
- 4061US2018162937A1Anti-5t4 antibodies and uses thereofWYETH LLC·Filed 2018·Application pending·0 cites
- 4161US2013302250A1Single domain binding moleculeUNIV ABERDEEN·Filed 2013·Application pending·0 cites
- 4260US11578428B2Humanized antibodiesPFIZER·Filed 2020·Granted Feb 14, 2023·0 cites·15 claims
- 4360US9409981B2Antibody to GDF8 and uses thereofPFIZER·Filed 2013·Granted Aug 9, 2016·0 cites·16 claims
- 4460US2024059799A1Anti-tl1a antibodies and methods of use thereofPFIZER·Filed 2023·Application pending·0 cites
- 4560US2014081005A1Antibody-drug conjugatesWYETH LLC·Filed 2013·Application pending·0 cites
- 4659US2024117030A1Multispecific antibodies and uses thereofPFIZER·Filed 2023·Application pending·0 cites
- 4757US2020123260A1Bispecific antibodiesPFIZER·Filed 2019·Application pending·0 cites
- 4855US2006088522A1Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugatesWYETH CORP·Filed 2005·Application pending·0 cites
- 4954US2020069764A1Antibodies and antibody fragments for site-specific conjugationPFIZER·Filed 2019·Application pending·0 cites
- 5054US2017319711A1Antibody-drug conjugatesWYETH LLC·Filed 2016·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lioudmila Tchistiakova files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →